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ABSTRACT
Introduction: Portugal is experiencing the effects of the COVID-19 pandemic since March 2020. All-causes mortality in Portugal 
increased during March and April 2020 compared to previous years, but this increase is not explained by COVID-19 reported deaths. 
The aim of this study was to analyze and consider other criteria for estimating excessive all-cause mortality during the early COVID-19 
pandemic period. 
Material and Methods: Public data was used to estimate excess mortality by age and region between March 1 and April 22, proposing 
baselines adjusted for the lockdown period. 
Results: Despite the inherent uncertainty, it is safe to assume an observed excess mortality of 2400 to 4000 deaths. Excess mortality 
was associated with older age groups (over age 65). 
Discussion: The data suggests a ternary explanation for early excess mortality: COVID-19, non-identified COVID-19 and decrease in 
access to healthcare. The estimates have implications in terms of communication of non-pharmaceutical actions, for research, and to 
healthcare professionals. 
Conclusion: The excess mortality occurred between March 1 and April 22 was 3 to 5 fold higher than what can be explained by the 
official COVID-19 deaths. 
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RESUMO
Introdução: Desde março 2020, Portugal tem sofrido os efeitos da pandemia COVID-19. A mortalidade por todas as causas aumen-
tou em março e abril de 2020 comparativamente a anos anteriores, mas este aumento não é explicado pelas mortes reportadas de 
COVID-19. O objetivo deste estudo foi analisar e considerar outros critérios para estimar o excesso de mortalidade durante a pande-
mia COVID-19. 
Material e Métodos: Utilizaram-se bases de dados públicas para estimar o excesso de mortalidade por idade e região entre 1 de 
março e 22 de abril, propondo níveis basais ajustados ao período de estado de emergência em vigor. 
Resultados: Apesar da incerteza inerente, é seguro assumir um excesso de mortalidade observada de 2400 a 4000 mortes. O exces-
so de mortalidade encontra-se associado aos grupos etários mais idosos (idade superior a 65 anos). 
Discussão: Os dados sugerem uma explicação tripartida para o excesso de mortalidade: COVID-19, COVID-19 não identificado e 
diminuição do acesso a cuidados de saúde. As estimativas efetuadas possuem implicações ao nível da comunicação de acções não 
farmacológicas, da investigação científica e dos profissionais de saúde. 
Conclusão: Da análise dos resultados é possível concluir que o excesso de mortalidade ocorrido entre 1 de março e 22 de abril foi 3 
a 5 vezes superior ao explicado pelas mortes por COVID-19 reportadas oficialmente.
Palavras-chave: Coronavírus; Infecções por Coronavírus; Mortalidade; Pandemia; Portugal; Surtos de Doenças 
INTRODUCTION
 On March 2, 2020 the first infections by SARS-CoV-2 were reported in Portugal. Currently (April 22) 21982 infections 
and 785 deaths have occurred in individuals infected with the SARS-CoV-2 virus.1 Public health surveillance data reg-
istered 10096 deaths in all-causes mortality during March 2020,2 a significant increase compared to data from previous 
years for the same period. This suggests potential excess mortality attributable to crisis conditions. The excess mortality 
observed is not explained by the number of official COVID-19 deaths during the same period. 
 The standard approach to calculate the expected number of deaths, in the absence of a given event of interest, uses 
the previous year’s historical data for the same period (either mean or median) as baseline reference.5 In the current pan-
demic situation, several studies and newspaper articles are using this approach. However, the current lockdown situation 
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is not comparable with any historical mortality reported so far, and therefore this approach does not reflect the expected 
mortality in the current situation. 
 In fact, the current lockdown situation can be thought as having some similarities to a summer holiday period, given 
lower levels of working population, lower risk of infectious diseases (due to weather in the summer and due to quarantine 
during the lockdown), less urban traffic and road traffic accidents, but also lower number of consultations. Therefore, the 
current situation may not be comparable to the same periods in previous years, implying a reduction in expected mortality 
towards the level of one month of summer holidays. If the lockdown had some protective effect on overall mortality, like 
summer holiday months seem to have, these effects may be observed some, if not all, age groups.
 The aim of this study was to analyze and consider other criteria for estimating excessive all-causes mortality during the 
COVID-19 pandemic period, discussing possible contributions and implications in the context of this unusual phenomena.
MATERIAL AND METHODS
 Our study consisted of the analysis of official public datasets, including on COVID-19. Using this methodology of 
anonymized public data dismissed the need of ethics committee approval. We retrieved, from the 1st March to the 22nd 
April 2020, data from public datasets on COVID-19 confirmed cases and mortality,3 distribution per district of COVID-19 
confirmed cases,1 all-cause daily mortality (total, by age group and by district) available from the electronic surveillance 
of mortality in real-time from the Portuguese e-Death Certification Information System (SICO/eVM),2 and access to emer-
gency services according to the Manchester Triage System.4
 We herein considered the minimum observed mortality in the period, or what would be expected within one, three, 
or five months ahead as more plausible baselines for the current situation. In our analysis we also present the maximum 
observed mortality in the period, not because it is a good alternative, but because it may show clear excess mortality in the 
study period. Throughout our calculations up to March 11, any excess mortality was assumed to be zero. Baselines were 
obtained smoothing the respective mortalities series.
 We calculated the excess mortality estimates considering Excess mortality (∑ observed – ∑ defined baseline) and Sum 
of Positive Excess Mortality (∑ [observed – defined baseline] when this difference is positive).
 The estimation of excess mortality rates and COVID-19 mortality rates were performed by district of mainland Portugal, 
in absolute and relative terms, both per 100,000 inhabitants per district.     
 We estimated mortality due to reduction of daily-rate hospital Emergency Department (ED) visits between March 1 
– April 22. We retrieved the data6 on ED visits according to the Manchester Triage System (MTS).7 The estimation was 
performed in 3 steps: Step 1- for each MTS triage color, we calculated the 3-day average in the beginning of march (1st to 
3rd of march); From day 3 onwards, within each MTS color, we calculated the difference between the number of each day 
visits (3-day centered averages) and the 3-day average in the beginning of march (reference); Step 2- We calculated the 
total number of visits (difference between daily averages) corresponding to the sum of these daily differences, according 
to the MTS color; Step 3- The values obtained in step 2 for each MTS color were multiplied by the corresponding assumed 
death rates of 10.3% for MTS red color, 4% for MTS orange color and 0.00003% for MST yellow color,7 and the sum of 
values represented the total number of potential deaths.
 The estimates were performed using R software (version 3.4.4). Code is available upon request. 
RESULTS
 First, we estimated the excess mortality from the 1st of March to the 22nd of April 2020 (Fig. 1). Results presented in Fig. 
1A) show a sustained observed mortality above the usual and the new proposed alternative baselines during most of the 
month of March and April. Excess mortality seems associated with the increasing number of observed official COVID-19 
deaths (Fig. 1B).
 When excess mortality was calculated under mean and median usual standards, we observed a 2- to 3-fold increase 
in excess mortality accounted officially as COVID-19 deaths (Fig. 1B). In our proposed alternative baseline setting, this ex-
cess mortality was remarkably higher, registering a 3.5- to 5-fold increase compared to the official COVID-19 mortality (Fig. 
1B). Despite the inherent uncertainty, it is safe to assume an observed excess mortality of 2400 to 4000 deaths between 
March 1 and April 22.
 Table 1 shows the estimation of excess mortality using all-cause mortality by age group and baseline mortality defini-
tion. It can be observed that the estimated excess mortality is associated with the older age groups, with different baselines 
showing consistent results. Mortality in the younger age groups was, on average, below the proposed baselines, as hy-
pothesized.
 Our calculations indicate that the estimated excess mortality was associated with higher age groups (Fig. 1C), with the 
different baselines showing consistent results. Mortality in younger age groups was below average, and consistent with the 
different alternative baselines (see Table 1). 
 Considering the all-cause mortality by district of mainland Portugal (12 of 18 districts), some districts like Aveiro, Porto 
and Lisbon were characterized by a marked excess mortality (Fig. 2), meaning that in absolute terms, the estimated excess 
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mortality is geographically superimposed with districts where more COVID-19 cases were observed and which are more 
densely populated (Fig. 3). In relative terms, estimated excess mortality seems overall homogeneous by district, tending to 
be higher in districts with older patients and lower population density (Fig. 4).
 A considerable reduction in the daily-rate emergency department (ED) visits occurred between March 1 - April 22 with a 
cumulative daily average difference of -191,666 visits for patients with MTS red (n= -771 visits), orange (n= -30159 visits), 
and yellow colors (n= -160,736 visits) (Fig. 5). Taking into account that despite the lockdown patients still require access 
to urgent and emergency care, and assuming the proportions of short-term mortality occurring within the ED 24 - 48 hours 
after admission, we estimated a potential of, at least, 1291 deaths (MTS red color: 79 deaths; MTS orange color: 1206 
deaths; MTS yellow color: six deaths) could have occurred between March 1 and April 22 2020 because of the reduction 
in ED visits (see Appendix 1: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13928/Appen-
dix_01.pdf).
DISCUSSION
 This paper represents one of the first attempts to present different comparative scenarios and estimates of excess 
mortality during the early stages of the COVID-19 pandemic in Portugal. This pandemic poses an unprecedented challenge 
to health systems globally, with a need to increase resource capacity across all health services, thus implying a significant 
healthcare burden with potential life threatening outcomes as reported in Italy and Spain. Despite the general perception 
that Portugal intervened rapidly to mitigate the COVID-19 effects, it is clear that none of the current monitoring instruments 
were prepared to perform with precision under lockdown conditions: the current monitoring instruments produce under-
estimations of excess mortality given they were conceived assuming normal expected conditions (not accounting for the 
current special condition). Several studies were carried out under the same kind of assumptions, for example, a report 
produced by Statistics Portugal calculates the excess mortality in Portugal by Municipalities for March 2020, comparing 
only with March of 2018 and 2019,8 not considering the specific effect on the older age groups. Overall, this implies the 
need for monitoring and surveillance instruments to be able to perform in scenarios like the current one.
 The explanation for this increase in all-cause mortality that occurred in the over 65 age group appears ternary: (i) 
COVID-19; (ii) non-identified COVID-19; and (iii) decrease in access to healthcare. Considering that COVID-19 and non-
identified COVID-19 increase mortality may be related to healthcare burden, the potential impact in all-cause mortality due 
to decrease in access to healthcare justifies a more thorough discussion. From the health services perspective, the focus 
on COVID-19 preparedness implied postponing programmed surgeries and outpatient consultations for a considerable 
number of patients with chronic conditions. Considering the public perspective, the announcement of the non-pharma-
ceutical interventions taken by the government to control the epidemic (Fig. 1), largely disseminated by the media, might 
have triggered the public perception that healthcare visits should be avoided (due to concerns of potential infection from 
healthcare facilities). This is illustrated by the notorious reduction of more than 191,000 daily hospital ED visits occurred 
between March 1 - April 22, potentially impacting in 1291 or more deaths [Fig. 5 and Table in Appendix (see Appendix 1: 
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/13928/Appendix_01.pdf)].
 Nevertheless, the hypothesis of a potential mortality displacement effect10 should not be ruled out, given the minimum 
registered number of deaths expected for February, while considering the absence of a significant seasonal influenza activ-
ity11 and the warm temperatures experienced during this period.12 However, excess mortality occurred in the second half of 
March, coincidental with the lockdown and persisting continuously since then. While lockdown measures do not promote 
the same behavior as summer vacation months, both situations result in lower mortality risk: In fact, the lowest mortality 
rates are observed during the summer months, and the aim of the lockdown is to reduce the health risks of citizens. It 
should be noted that the number of excess deaths observed has a much higher magnitude than the number of deaths in 
subjects infected with COVID-19. Of these deaths, only a certain proportion yet to be clearly defined will have died because 
of the infection. Therefore, at least in this early phase of the epidemic, it is unlikely that deaths due to known or unknown 
COVID-19 infections would account for the total observed excess mortality.
 It is of interest to note that no excess mortality was observed in the under 55 year age group. In fact, this group re-
mained around the average daily number of deaths observed in the past twelve years, including the summer months, and 
there was actually an improvement in the average number of deaths in the last two weeks (Fig. 1C). This suggests that 
mortality for the majority of the population (individuals below age 55) benefited from this lockdown period with a similar 
magnitude as during the summer holiday months, as hypothesized. However, and despite these conditions, excess mortal-
ity was observed in the group above age 55, and in the elderly in particular.
 The estimates of this paper imply a call for action with implications for policy, research, healthcare professionals (espe-
cially family physicians and pharmacists) and the general public. For policy, it is important to clearly communicate that the 
announced non-pharmaceutical interventions should not preclude the access to healthcare services, especially for patients 
with chronic conditions and comorbidities, in order to prevent the increase in deaths for lack of access while attempting 
to focus on decreasing COVID-19 related deaths. District-level preparedness plans are important to prevent alarm and 


















































correct message. This measure may impact directly on mortality as demonstrated in the present study for the over 65 age 
group, considering the high prevalence of chronic diseases in this specific age group.13 
 For research, it is important to acknowledge that, presently, the actions of both healthcare and academic institutions 
focus on mitigating the effects of the COVID-19 pandemic. However, it is important to carry out research in other Public 
Health/Epidemiological areas of interest (Environmental, Occupational, Neuro-Psychiatric Epidemiology) potentially im-
pacted by the COVID-19 pandemic and that can cause an increase in all-cause mortality. Facilitating access to public 
health data (hospital registries, etc.) is important to support public health interventions. This study contributes conceptually 
for opening the mindset and promoting discussion concerning the definition of excessive mortality and future analysis of 
factors that impact early excess mortality not associated with COVID-19.
 The results of this study should be interpreted with caution, considering the limitations of projecting working scenarios 
at an early stage of the pandemic and with considerable uncertainty. Future research should be performed with more de-
finitive data to finely quantify (and qualify) excess mortality; of paramount importance will be the inclusion of the individual 
causes of death. 
CONCLUSION
 It is possible to conclude that there is evidence of excess mortality in Portugal between March 1 and April 22, 2020 
during the COVID-19 lockdown even using the usual baselines (mean, median).
 By adopting baselines more consistent with the lockdown, the excess mortality becomes more evident, with estimated 
2400 to 4000 potential excess deaths during this period. 
 The observed excess of mortality is associated with older age groups (over age 65). The reduction of more than 
191,000 daily hospital ED visits occurred between March 1 - April 22 may potentially be associated with 1291 or more 
deaths. Overall, these results point towards an excess mortality that is associated with and that is 3 to 5-fold higher than 
the official COVID-19 mortality.
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< 65  
age group
< 55 
age group All ages
Baseline Exc1 Exc2 Exc1 Exc2 Exc1 Exc2 Exc1 Exc2 Exc1 Exc2
Minimum 2991.0 2991.0 3372.0 3372.0 458.0 467.0 233.0 249.0 4022.0 4022.0
Maximum 316.0 823.0 360.0 938.0 -382.0 50.0 -345.0 12.0 192.0 859.0
Median 1754.0 1784.0 1955.5 2006.5 55.5 164.0 -28.5 77.5 2323.0 2364.0
Mean 1683.0 1731.4 1896.6 1959.2 58.2 164.4 -19.4 80.8 1821.0 1881.8
Mean + 1 month 2427.8 2505.6 2703.2 2802.0 85.8 171.2 -19.6 78.0 2919.0 2827.0
Mean + 3 months 3264.4 3165.2 3642.2 3552.8 117.0 186.0 -13.0 84.0 4161.3 3773.2
Mean + 5 months 3364.2 3246.8 3796.8 3669.0 89.0 169.6 -26.2 74.8 3967.5 3783.0
Exc1: Excess mortality (∑ observed - ∑ defined baseline); Exc2: Sum of positive excess mortality (∑ [observed - defined baseline] when this difference is positive).
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Figure 1 – Evolution between March 1 and April 22, 2020. (A) All-cause mortality with indication of the main non-pharmaceutical interven-
tions by the Portuguese Government in chronological order. All baselines were smoothed. Note the excess mortality from the second half 
of March onwards. (B) Cumulative excess mortality estimation compared with COVID-19 official mortality: Exc1 – Excess mortality: (∑ 
observed – ∑ defined baseline) on the left-hand side; Exc2 – Sum of Positive Excess Mortality: (∑ [observed – defined baseline] when 
this difference is positive) on the right-hand side. (C) Age-specific evolution of all-cause mortality. All baselines were smoothed. Note the 
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Figure 2 – Graphical illustration for district-specific distribution of all-cause mortality between March 6 - April 22, 2020, for Mainland Por-
tugal Districts. Graphical comparison depicts observed mortality (magenta line), minimum baseline (red line), maximum baseline (orange 
line), mean baseline (yellow dashed line), median baseline (grey dashed line), mean + 1 month baseline (light blue dashed line), mean + 
3 months baseline (dark blue dashed line) and mean + 5 months baseline (rose dashed line). Note some Districts (Aveiro, Porto, Lisbon) 


















































Figure 3 – Graphical representation of estimated excess mortality and COVID-19 estimated mortality in absolute terms. Vertical blue lines 
represent the distance between minimum and the maximum of estimated excess mortality calculated using 3 different baselines (mean + 
1 month, mean + 3 months and mean + 5 months). COVID-19 [Cov_Est] mortality was estimated from municipal cases reported by DGS 
using three hypothetical death rates (3%, 4% and 5%).
R: Pearson correlation coefficient; Rho: Spearman correlation coefficient; Exc1: Excess mortality - (Σ observed – Σ defined baseline); Exc2: Sum of Positive Excess Mortality - (Σ 
[observed – defined baseline] when this difference is positive).
Figure 4 – Graphical representation of estimated excess mortality rates and COVID-19 estimated mortality rates in relative terms, both 
by 100,000 inhabitants per district. Vertical blue lines represent the distance between minimum and the maximum of estimated excess 
mortality calculated using 3 different baselines (mean + 1 month, mean + 3 months and mean + 5 months). COVID-19 [Cov_Est] mortality 
was estimated from municipal cases reported by DGS using three hypothetical death rates (3%, 4% and 5%).
R: Pearson correlation coefficient; Rho: Spearman correlation coefficient; Exc1: Excess mortality - (Σ observed – Σ defined baseline); Exc2: Sum of Positive Excess Mortality - (Σ 
[observed – defined baseline] when this difference is positive).

















































































Figure 5 – Emergency department visits between March 1 – April 22, 2020, in Portugal Mainland (counts, 3-day centered averages). Color 
lines according to the 5-point scale of the Manchester Triage System in crescent order of severity: Blue, Green, Yellow, Orange, Red.7   
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Supplementary material 
 
Estimation of the potential impact in mortality due to reduction of daily-rate hospital ED visits 
between March 1 – April 22, 2020 
We retrieved the data on ED visits according to the Manchester Triage System1 from a public 
database.2 The estimate was performed in 3 steps: 
Step 1- Three-day centered average counts of the daily visits between March 1 - April 22, 2020; 
We calculated the decrease in the number of ED visits, according to the Manchester System 
Triage color in the following way: for each triage color, we calculated the 3-day average in the 
beginning of march (1st to 3rd of march) (Step 1). From day 3 onwards, within each color, we 
calculated the difference between the number of each day visits (3-day centered averages) and 
the 3-day average in the beginning of March (reference).   
Step 2- The total number of visits presented in Table S1 (‘Difference between daily averages’) 
corresponded to the sum of these daily differences, according to the triage color; 
Step 3- The values obtained in step 2 for each Manchester Triage System color were multiplied 
by the corresponding assumed death rate 1 and the sum of values represented the number of 
potential deaths (Table S1).  
Table S1. Average difference in ED visits between March 1 and April 22, 2020, 
in Mainland Portugal according to the Manchester Triage System. 




daily averages Death rate*  
N potential deaths 
(step 2 * death rate) 
Red color |- 771| 10.3 % 79 
Orange color |-30159| 4% 1206 
Yellow color |-160,736| 0.00003% 6 
Total number of deaths 1291 
 
* Death rate per Manchester Triage System 1 
Data for the remaining colors of the Manchester Triage System are not shown due to 
the non-significant contribution to the potential deaths. 
 
Considering the previous steps and assumptions, an estimate of at least 1291 deaths due to the 
reduction in ED department visits between March 1 and April 22 could be hypothesized. These 
potential 1291 deaths are considered to be an underestimation of the real number of deaths. 
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